![](/img/cover-not-exists.png)
O-011 * Characteristics and outcomes of patients enrolled in the CORRECT and CONCUR phase 3 trials of regorafenib for metastatic colorectal cancer (mCRC)
Grothey, A., Van Cutsem, E., Wagner, A., Kalmus, J., Qin, S., Xu, R., Kim, T. W., Li, J.Volume:
26
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv235.10
Date:
June, 2015
File:
PDF, 99 KB
2015